Becton, Dickinson and Company, BD Biosciences recalls BD FMC7 FITC: Model 430918. FMC7 is intended for in vitro diagnostic use in the identification of cells expressing FMC7…
- Recall date
- January 25, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0851-2016
- FDA classification
- Class III
- Brand / firm
- Becton, Dickinson and Company, BD Biosciences
- Sold / distributed
- Worldwide Distribution - US Nationwide in the staates of TX, NY, GA, NJ, AL, MA, IL, PA, DC, FL, CA, MD, OK. and coutry of Taiwan.
Why it was recalled
Becton, Dickinson and Company (BD) has determined that the FMC7 FITC (ASR) has an incorrect expiration date listed on the vial label.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
BD FMC7 FITC: Model 430918. FMC7 is intended for in vitro diagnostic use in the identification of cells expressing FMC7 antigen. Product Usage: Analyte Specific Reagent. FMC7 is intended for in vitro diagnostic use in the identification of cells expressing FMC7 antigen.
Get recall alerts
Free email alert whenever Becton, Dickinson and Company, BD Biosciences has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Becton, Dickinson and Company, BD Biosciences